Martin J. Duvall
2017
In 2017, Martin J. Duvall earned a total compensation of $4.4M as Chief Executive Officer at Forte Biosciences, a 40% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $265,462 |
|---|---|
| Option Awards | $3,625,194 |
| Salary | $446,154 |
| Other | $59,914 |
| Total | $4,396,724 |
Duvall received $3.6M in option awards, accounting for 82% of the total pay in 2017.
Duvall also received $265.5K in non-equity incentive plan, $446.2K in salary and $59.9K in other compensation.
Rankings
In 2017, Martin J. Duvall's compensation ranked 2,271st out of 14,666 executives tracked by ExecPay. In other words, Duvall earned more than 84.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,271 out of 14,666 | 85th |
Division Manufacturing | 791 out of 5,772 | 86th |
Major group Chemicals And Allied Products | 213 out of 2,075 | 90th |
Industry group Drugs | 162 out of 1,731 | 91st |
Industry Pharmaceutical Preparations | 127 out of 1,333 | 91st |
Source: SEC filing on April 30, 2018.
Duvall's colleagues
We found three more compensation records of executives who worked with Martin J. Duvall at Forte Biosciences in 2017.